vs

Side-by-side financial comparison of CABOT CORP (CBT) and RPC INC (RES). Click either name above to swap in a different company.

CABOT CORP is the larger business by last-quarter revenue ($849.0M vs $425.8M, roughly 2.0× RPC INC). CABOT CORP runs the higher net margin — 8.6% vs -0.7%, a 9.3% gap on every dollar of revenue. On growth, RPC INC posted the faster year-over-year revenue change (27.0% vs -11.1%). CABOT CORP produced more free cash flow last quarter ($57.0M vs $31.2M). Over the past eight quarters, RPC INC's revenue compounded faster (6.2% CAGR vs -8.7%).

Cabot Corporation is an American specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company operates in over 20 countries with 36 manufacturing plants, eight research and development facilities, and 28 sales offices.

RPC Group plc is based in the United Kingdom, and is one of Europe's largest supplier of plastic packaging. Its headquarters are in Rushden in Northamptonshire. It was listed on the London Stock Exchange until it was acquired in 2019 by Berry Global Group Inc, which in turn was acquired by Amcor in 2025.

CBT vs RES — Head-to-Head

Bigger by revenue
CBT
CBT
2.0× larger
CBT
$849.0M
$425.8M
RES
Growing faster (revenue YoY)
RES
RES
+38.1% gap
RES
27.0%
-11.1%
CBT
Higher net margin
CBT
CBT
9.3% more per $
CBT
8.6%
-0.7%
RES
More free cash flow
CBT
CBT
$25.8M more FCF
CBT
$57.0M
$31.2M
RES
Faster 2-yr revenue CAGR
RES
RES
Annualised
RES
6.2%
-8.7%
CBT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CBT
CBT
RES
RES
Revenue
$849.0M
$425.8M
Net Profit
$73.0M
$-3.1M
Gross Margin
24.9%
21.0%
Operating Margin
15.2%
-0.9%
Net Margin
8.6%
-0.7%
Revenue YoY
-11.1%
27.0%
Net Profit YoY
-21.5%
-124.0%
EPS (diluted)
$1.37
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBT
CBT
RES
RES
Q4 25
$849.0M
$425.8M
Q3 25
$899.0M
$447.1M
Q2 25
$923.0M
$420.8M
Q1 25
$936.0M
$332.9M
Q4 24
$955.0M
$335.4M
Q3 24
$1.0B
$337.7M
Q2 24
$1.0B
$364.2M
Q1 24
$1.0B
$377.8M
Net Profit
CBT
CBT
RES
RES
Q4 25
$73.0M
$-3.1M
Q3 25
$43.0M
$13.0M
Q2 25
$101.0M
$10.1M
Q1 25
$94.0M
$12.0M
Q4 24
$93.0M
$12.8M
Q3 24
$137.0M
$18.8M
Q2 24
$109.0M
$32.4M
Q1 24
$84.0M
$27.5M
Gross Margin
CBT
CBT
RES
RES
Q4 25
24.9%
21.0%
Q3 25
24.5%
25.1%
Q2 25
26.4%
24.5%
Q1 25
25.7%
26.7%
Q4 24
24.6%
25.4%
Q3 24
24.0%
26.7%
Q2 24
25.2%
28.0%
Q1 24
24.1%
26.8%
Operating Margin
CBT
CBT
RES
RES
Q4 25
15.2%
-0.9%
Q3 25
15.2%
4.7%
Q2 25
18.1%
3.7%
Q1 25
17.3%
3.7%
Q4 24
16.2%
3.1%
Q3 24
15.0%
5.7%
Q2 24
16.9%
9.7%
Q1 24
15.3%
8.6%
Net Margin
CBT
CBT
RES
RES
Q4 25
8.6%
-0.7%
Q3 25
4.8%
2.9%
Q2 25
10.9%
2.4%
Q1 25
10.0%
3.6%
Q4 24
9.7%
3.8%
Q3 24
13.7%
5.6%
Q2 24
10.7%
8.9%
Q1 24
8.2%
7.3%
EPS (diluted)
CBT
CBT
RES
RES
Q4 25
$1.37
$-0.02
Q3 25
$0.80
$0.06
Q2 25
$1.86
$0.05
Q1 25
$1.69
$0.06
Q4 24
$1.67
$0.06
Q3 24
$2.41
$0.09
Q2 24
$1.94
$0.15
Q1 24
$1.49
$0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBT
CBT
RES
RES
Cash + ST InvestmentsLiquidity on hand
$230.0M
$210.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.6B
$1.1B
Total Assets
$3.8B
$1.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBT
CBT
RES
RES
Q4 25
$230.0M
$210.0M
Q3 25
$258.0M
$163.5M
Q2 25
$239.0M
$162.1M
Q1 25
$213.0M
$326.7M
Q4 24
$183.0M
$326.0M
Q3 24
$223.0M
$276.9M
Q2 24
$197.0M
$261.5M
Q1 24
$206.0M
$212.2M
Total Debt
CBT
CBT
RES
RES
Q4 25
Q3 25
$1.1B
Q2 25
Q1 25
Q4 24
Q3 24
$1.1B
Q2 24
Q1 24
Stockholders' Equity
CBT
CBT
RES
RES
Q4 25
$1.6B
$1.1B
Q3 25
$1.6B
$1.1B
Q2 25
$1.5B
$1.1B
Q1 25
$1.4B
$1.1B
Q4 24
$1.4B
$1.1B
Q3 24
$1.4B
$1.1B
Q2 24
$1.3B
$1.1B
Q1 24
$1.4B
$1.0B
Total Assets
CBT
CBT
RES
RES
Q4 25
$3.8B
$1.5B
Q3 25
$3.8B
$1.5B
Q2 25
$3.8B
$1.5B
Q1 25
$3.8B
$1.3B
Q4 24
$3.6B
$1.4B
Q3 24
$3.7B
$1.3B
Q2 24
$3.6B
$1.3B
Q1 24
$3.6B
$1.3B
Debt / Equity
CBT
CBT
RES
RES
Q4 25
Q3 25
0.70×
Q2 25
Q1 25
Q4 24
Q3 24
0.75×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBT
CBT
RES
RES
Operating Cash FlowLast quarter
$126.0M
$61.9M
Free Cash FlowOCF − Capex
$57.0M
$31.2M
FCF MarginFCF / Revenue
6.7%
7.3%
Capex IntensityCapex / Revenue
8.1%
7.2%
Cash ConversionOCF / Net Profit
1.73×
TTM Free Cash FlowTrailing 4 quarters
$401.0M
$52.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBT
CBT
RES
RES
Q4 25
$126.0M
$61.9M
Q3 25
$219.0M
$46.5M
Q2 25
$249.0M
$53.1M
Q1 25
$73.0M
$39.9M
Q4 24
$124.0M
$94.2M
Q3 24
$204.0M
$70.7M
Q2 24
$207.0M
$127.9M
Q1 24
$176.0M
$56.6M
Free Cash Flow
CBT
CBT
RES
RES
Q4 25
$57.0M
$31.2M
Q3 25
$155.0M
$4.1M
Q2 25
$188.0M
$10.0M
Q1 25
$1.0M
$7.6M
Q4 24
$47.0M
$53.7M
Q3 24
$112.0M
$19.1M
Q2 24
$155.0M
$52.9M
Q1 24
$133.0M
$3.8M
FCF Margin
CBT
CBT
RES
RES
Q4 25
6.7%
7.3%
Q3 25
17.2%
0.9%
Q2 25
20.4%
2.4%
Q1 25
0.1%
2.3%
Q4 24
4.9%
16.0%
Q3 24
11.2%
5.6%
Q2 24
15.3%
14.5%
Q1 24
13.1%
1.0%
Capex Intensity
CBT
CBT
RES
RES
Q4 25
8.1%
7.2%
Q3 25
7.1%
9.5%
Q2 25
6.6%
10.2%
Q1 25
7.7%
9.7%
Q4 24
8.1%
12.1%
Q3 24
9.2%
15.3%
Q2 24
5.1%
20.6%
Q1 24
4.2%
14.0%
Cash Conversion
CBT
CBT
RES
RES
Q4 25
1.73×
Q3 25
5.09×
3.59×
Q2 25
2.47×
5.23×
Q1 25
0.78×
3.31×
Q4 24
1.33×
7.38×
Q3 24
1.49×
3.76×
Q2 24
1.90×
3.95×
Q1 24
2.10×
2.06×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBT
CBT

Reinforcement Materials$520.0M61%
Performance Chemicals$300.0M35%
Shipping And Handling$25.0M3%
Other Products And Services$4.0M0%

RES
RES

Technical Service$405.2M95%
Other$8.8M2%
Nitrogen$6.6M2%

Related Comparisons